In this on-demand webcast, an expert discusses the latest developments in the use of BTK inhibitors as a targeted therapy for B-cell lymphomas. Tune in for a discussion about the mechanisms of action, emerging treatment regimens, and patient management strategies to enhance outcomes.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://practicingclinicians.com/activities/oncology/advances-in-btk-inhibitor-therapy-for-b-cell-lymphomas/28408-66442/info
- Start Date: 2024-12-11 06:00:00
- End Date: 2024-12-11 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours - Commercial Support: Source: BeiGene - Amount: 42500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest